Literature DB >> 27165417

Structure and function of multidrug and toxin extrusion proteins (MATEs) and their relevance to drug therapy and personalized medicine.

Anne T Nies1,2, Katja Damme3,4,5, Stephan Kruck6, Elke Schaeffeler3,4, Matthias Schwab3,7,8.   

Abstract

Multidrug and toxin extrusion (MATE; SLC47A) proteins are membrane transporters mediating the excretion of organic cations and zwitterions into bile and urine and thereby contributing to the hepatic and renal elimination of many xenobiotics. Transported substrates include creatinine as endogenous substrate, the vitamin thiamine and a number of drug agents with in part chemically different structures such as the antidiabetic metformin, the antiviral agents acyclovir and ganciclovir as well as the antibiotics cephalexin and cephradine. This review summarizes current knowledge on the structural and molecular features of human MATE transporters including data on expression and localization in different tissues, important aspects on regulation and their functional role in drug transport. The role of genetic variation of MATE proteins for drug pharmacokinetics and drug response will be discussed with consequences for personalized medicine.

Entities:  

Keywords:  Function; MATE; Metformin; Multidrug and toxin extrusion; Polymorphisms; SLC47

Mesh:

Substances:

Year:  2016        PMID: 27165417     DOI: 10.1007/s00204-016-1728-5

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  22 in total

Review 1.  Thermodynamic secrets of multidrug resistance: A new take on transport mechanisms of secondary active antiporters.

Authors:  Xuejun C Zhang; Min Liu; Guangyuan Lu; Jie Heng
Journal:  Protein Sci       Date:  2017-12-15       Impact factor: 6.725

2.  Effect of Excessive Serotonin on Pharmacokinetics of Cephalexin after Oral Administration: Studies with Serotonin-Excessive Model Rats.

Authors:  Shun Nakashima; Takeharu Iwamoto; Masashi Takanashi; Ken-Ichi Ogawara; Masato Maruyama; Kazutaka Higaki
Journal:  Pharm Res       Date:  2022-07-08       Impact factor: 4.580

3.  A Protocol for the Study of Polymorphisms and Response to Metformin in Patients with Type 2 Diabetes in Trinidad.

Authors:  Yuri Clement; Shamjeet Singh; Shastri Motilal; Rohan Maharaj; Marcella Nunez-Smith
Journal:  Ethn Dis       Date:  2020-04-02       Impact factor: 1.847

4.  Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2).

Authors:  Peng Zhu; Zhi Ye; Dong Guo; Zongping Xiong; Shiqiong Huang; Jun Guo; Wei Zhang; James E Polli; Honghao Zhou; Qing Li; Yan Shu
Journal:  Pharm Res       Date:  2018-10-25       Impact factor: 4.200

5.  Population diversity of three variants of the SLC47A2 gene (MATE2-K transporter) in Mexican Mestizos and Native Americans.

Authors:  Alma Faviola Favela-Mendoza; Ingrid Fricke-Galindo; Wendy Fernanda Cuevas-Sánchez; José Alonso Aguilar-Velázquez; Gabriela Martínez-Cortés; Héctor Rangel-Villalobos
Journal:  Mol Biol Rep       Date:  2021-08-12       Impact factor: 2.316

Review 6.  Transport of Drugs and Endogenous Compounds Mediated by Human OCT1: Studies in Single- and Double-Transfected Cell Models.

Authors:  Bastian Haberkorn; Martin F Fromm; Jörg König
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 7.  Molecular and cellular physiology of organic cation transporter 2.

Authors:  Stephen H Wright
Journal:  Am J Physiol Renal Physiol       Date:  2019-11-04

8.  Pharmacodynamics of Glyburide, Metformin, and Glyburide/Metformin Combination Therapy in the Treatment of Gestational Diabetes Mellitus.

Authors:  Diana L Shuster; Laura M Shireman; Xiaosu Ma; Danny D Shen; Shannon K Flood Nichols; Mahmoud S Ahmed; Shannon Clark; Steve Caritis; Raman Venkataramanan; David M Haas; Sara K Quinney; Laura S Haneline; Alan T Tita; Tracy A Manuck; Kenneth E Thummel; Linda Morris Brown; Zhaoxia Ren; Zane Brown; Thomas R Easterling; Mary F Hebert
Journal:  Clin Pharmacol Ther       Date:  2020-01-25       Impact factor: 6.875

9.  Current Understanding of Membrane Transporters as Regulators or Targets for Cisplatin-Induced Hearing Loss.

Authors:  Kyle Z Pasquariello; Jason M Dey; Jason A Sprowl
Journal:  Mol Pharmacol       Date:  2021-07-30       Impact factor: 4.054

10.  The Structure and Mechanism of Drug Transporters.

Authors:  Arthur G Roberts
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.